首页> 外文OA文献 >PMD28 Clinical And Budget Impact Of Using A Molecular Test To Detect Kras Mutations In Metastatic Colorectal Cancer Patients In Denmark

【2h】

PMD28 Clinical And Budget Impact Of Using A Molecular Test To Detect Kras Mutations In Metastatic Colorectal Cancer Patients In Denmark

机译：在丹麦，使用分子检测检测转移性结直肠癌患者的Kras突变对PMD28的临床和预算影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Cheng I; Hertz D; Huang J; Poulios N;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan. [J] . Bibeau F, Lopez-Crapez E, Di-Fiore F, Journal of Clinical Oncology . 2009 ,第7期

机译：FcγRIIa-FcγRIIIa多态性和KRAS突变对西妥昔单抗加伊立替康治疗转移性结直肠癌患者临床结局的影响。
2. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. [J] . Allegra CJ, Jessup JM, Somerfield MR, Journal of Clinical Oncology . 2009 ,第12期

机译：美国临床肿瘤学会临时临床意见：测试转移性结直肠癌患者的KRAS基因突变，以预测对抗表皮生长因子受体单克隆抗体治疗的反应。
3. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients [J] . Xiaojing Xu, Fei Huang, Minlu Cao, Journal of clinical laboratory analysis. . 2021 ,第9期

机译：下一代测序和基质辅助激光解吸/电离飞行时间质谱法的跨平台比较，用于检测来自转移结直肠癌患者的CFDNA中的KRAS / NRAS / BRAF / PIK3CA突变
4. Isolation of Circulating Tumor Cells from Patients with Metastatic Colorectal Cancer Using Label-Free Microfluidic Technology for Enumeration and Detection of KRAS, BRAF, PIK3CA Mutation [C] . Haiyan Emily Liu, Evelyn Kidess-Sigal, Melanie Triboulet, International Molecular Medicine Tri-Conference. . 2016

机译：使用无标记微流体技术分离转移性结肠直肠癌患者的循环肿瘤细胞进行募准和检测KRA，BRAF，PIK3CA突变
5. Glucose deprivation selects for KRAS and BRAF mutations in colorectal cancer. [D] . Yun, Jihye. 2009

机译：葡萄糖剥夺选择结直肠癌中的KRAS和BRAF突变。
6. KRAS NRAS and BRAF mutations detected by next generation sequencing and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy [O] . Gemma Bruera, Francesco Pepe, Umberto Malapelle, 2018

机译：通过一线FIr-B / FOx加贝伐单抗（BEV）进行三联化疗的下一代测序检测到的KRASNRAS和BRAF突变以及转移性结直肠癌（MCRC）患者的临床差异
7. PMD17 Clinical and budget impact of using a test to Detect Kras mutations in Metastatic Colorectal Cancer patients in the United States [O] . Cheng I., Hertz D., Huang J., 2015

机译：在美国，使用PMD17检测转移性结直肠癌患者的Kras突变对临床和预算的影响

PMD28 Clinical And Budget Impact Of Using A Molecular Test To Detect Kras Mutations In Metastatic Colorectal Cancer Patients In Denmark

著录项

相似文献

相关主题

期刊订阅